BANK OF AMERICA CORP /DE/ - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 32 filers reported holding EDGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$03000.0%0.00%
Q3 2018$0
-100.0%
300
-97.9%
0.00%
Q2 2018$15,000
-87.5%
14,209
-86.0%
0.00%
Q1 2018$120,000
+126.4%
101,814
+1699.2%
0.00%
Q4 2017$53,000
+178.9%
5,659
+221.9%
0.00%
Q3 2017$19,000
+533.3%
1,758
+402.3%
0.00%
Q2 2017$3,000
-90.3%
350
-89.7%
0.00%
Q1 2017$31,000
-3.1%
3,387
+32.5%
0.00%
Q4 2016$32,000
+357.1%
2,556
+278.7%
0.00%
Q3 2016$7,000
+133.3%
675
+120.6%
0.00%
Q2 2016$3,0000.0%306
+50.7%
0.00%
Q4 2015$3,0002030.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders